Type 1 diabetes: A predictable disease

doi:10.4239/wjd.v6.i3.380

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 3

This Article

(388)

(302)

(0)

(13398)

(88)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Diabetes. Apr 15, 2015; 6(3): 380-390
Published online Apr 15, 2015. doi: 10.4239/wjd.v6.i3.380

Full Size Figure Download Figure

Figure 3 The measurement of serum islet autoantibodies has made type 1 diabetes a predictable disease. Early identification of islet autoantibody positive individuals leads to improved clinical outcomes by decreasing the risk for diabetic ketoacidosis and potentially preserving beta cell mass through clinical prevention trials. T1D: Type 1 diabetes; INIT-II: Intranasal Insulin Trial.

Citation: Simmons KM, Michels AW. Type 1 diabetes: A predictable disease. World J Diabetes 2015; 6(3): 380-390
URL: https://www.wjgnet.com/1948-9358/full/v6/i3/380.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i3.380

Simmons KM, Michels AW. Type 1 diabetes: A predictable disease. World J Diabetes 2015; 6(3): 380-390 [PMID: 25897349 DOI: 10.4239/wjd.v6.i3.380]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.